tirzepatide indications Eli Lilly releases "promising" data for in fatty liver indication 🧠Let's break the drug tirzepatide

The Phase 2 trial followed participants through 48 weeks of treatment but did not include an extended washout observation period comparable to longer post-trial data available for Semaglutide

Our experienced team will explain how Methylcobalamin/Semaglutide mimics the GLP-1 hormone to reduce appetite and improve glucose control, while Cyanocobalamin/Tirzepatide activates both GLP-1 and GIP receptors for enhanced effects

In the first study DAPA (in a daily dose of 5 mg) was administered in 30 obese patients with T2D for 24 weeks [104]

Due to the medication mimicking 3 hormones, it may have a stronger appetite suppression effect